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SUMMARY: Noonan syndrome is a multiple congenital anomaly syndrome, inherited in an autosomal dominant pattern. We studied 31 patients
(18 males and 13 females) affected by this disorder regarding their clinical and genetic characteristics. The most frequent clinical fi dings were short
stature (71%); craniofacial dysmorphisms, especially hypertelorism, ptosis, downslanting of the palpebral fissures; short or webbed neck (87%); cardiac
anomalies (65%), and fetal pads in fingers and toes (70%). After studying the probands’ first-degree relatives, we made the diagnosis of Noonan
syndrome in more than one family member in three families. Therefore, the majority of our cases were sporadic.
DESCRIPTORS: Noonan syndrome. Valvar pulmonary stenosis. Autosomal dominant. Proband.
Noonan syndrome (NS), described
in 1963 by Noonan and Ehmke1, is
characterized by short stature, dys-
morphic craniofacial features, short or
webbed neck, congenital heart disease,
cryptorchidism in the males, skeletal
anomalies and bleeding diathesis.
Its incidence is not well charac-
terized, but is estimated at 1/1000 to
1/2500 2, which makes this disorder
one of most common syndromes
associated with congenital heart dis-
ease.
The majority of the cases are
sporadic, but familial transmission has
been well documented 3,4, consistent
with an autosomal dominant pattern of
inheritance. There is a preponderance
of maternal transmission, which is
attributed to the cryptorchidism in the
males and consequent infertility.
The gene responsible for NS was
mapped to the long arm of chromo-
some 12 5,6, but some families have no
linkage to this region, indicating
genetic heterogeneity in this disorder 5.
We were interested in studying the
clinical and genetic aspects of this
syndrome due to its frequency and its
wide phenotypic spectrum.
METHODS
We identified 31 patients affected
by NS, derived from 26 families.
The ascertained proband and his
first-degree relatives underwent a stan-
dardized questionnaire and physical
examination. They were classified as
affected by this disorder based on the
clinical criteria described by van der
Burgt et al. 5, 1994. For those individu-
als classified as affected, a complete
cardiac work-up, comprising EKG and
echocardiogram, an abdominal ultra-
sound, column and wrist X-rays, oph-
thalmological examination, and coagu-
lation studies were performed. These
latter consisted of a bleeding time (BT)
by the Ivy method, a prothrombin time,
an activated partial thromboplastin
time, a thrombin time, a platelet count,
and a coagulation assay for factor XI.
If any of these studies yielded abnor-
mal results, it was followed by a more
extensive work-up. Karyotyping was
done in all probands.
The patients were included in this
study only after a written consent was
obtained.
RESULTS
Thirty-one patients (18 males and 13
females) were included in this study.
Their ages ranged from 3 months to 41
years (mean 12 years). Twelve probands
(46%) were white, 10 were mulatto
(38%), 3 were black (12%), and 1 was
oriental (4%).
The mean age of the diagnosis in the
probands was 6 years and 9 months.
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PRENATAL AND BIRTH DATA
Complications during pregnancy
were observed in 11 gestations out of
30 (36%); one patient was adopted and
there was no record of that period. The
most frequent complications were
premature contractions and vaginal
bleeding (20%) and polyhydramnios
(10%).
The majority of the patients were
born at term (90%), by cesarean
section (50%).
Birth weight was known in 27
babies born at term, with a mean of
3365 g for the females and 3445 g for
the males. Length was known in 22
patients with a mean of 48.05 cm for
the females and 48.5 cm for the males.
Some anomalies of NS, such as
congenital heart defect and lymph-
edema were observed in 23% and 13%
of the patients, respectively, in the
neonatal period.
The stay in the nursery ranged from
1 to 30 days (mean 7 days).
CLINICAL FINDINGS (Table 1)
CARDIAC FINDINGS
Twenty patients (65%) had conge-
nital heart defects (Table 2).
A superior deviation of the QRS
axis was frequently found in the EKG
(52%), not associated with a specific
heart defect. Signs of right ventricular
hypertrophy were present in 13 pa-
tients and left ventricular hypertrophy
in 5.
HEMATOLOGICAL EVALUATION
Six patients showed a tendency to
bleed, usually mild, characterized by
hematomas, epistaxes, and a prolonged
bleeding time.
The coagulation assays in these
patients revealed anomalies in nine of
them (Table 3).
GENETIC ASPECTS
We examined all first-degree rela-
tives of the probands, personally (68%)
or by photographs (32%), except for
two: one patient was adopted and the
father of another child was not availa-
ble. In the remaining 24 families, three
(12.5%) had more than one affected
person.
Table 2 - Congenital heart defects observed in 31 patients with NS.
     CARDIAC ANOMALIES N (%)
•  VPS and/or SVPS 10/23 (43%)
•  VPS/ASD 3/23 (13%)
•  VPS/MVP 1/23 (4%)
•  VPS/HCM 3/23 (13%)
•  HCM 4/23 (17%)
•  VSD 1/23 (4%)
•  Valvar aortic thickened 1/23 (4%)
VPS and/or SVPS= Valvar pulmonary stenosis/supravalvar pulmonary stenosis
VPS/ASD = Valvar pulmonary stenosis/atrial septal defect
VPS/MVP = Valvar pulmonary stenosis/mitral valve prolapse
VPS/HCM = Valvar pulmonary stenosis/hypertrophic cardiomyopathy
HCM = Hypertrophic cardiomyopathy
VSD = Ventricular septal defect
Table 1 - Clinical findings in 31 patients with NS.
     CLINICAL FINDINGS Nº (%)
GENERAL
Short stature 22/31 (71%)




Downslanting palpebral fissures 14/31 (45%)
Epicanthi 12/31 (39%)
Proptosis 4/30 (13%)
Fundus anomalies (eyes) 2/24 (8%)
Anterior segment anomalies (eyes) 3/12 (25%)
High arched palate 13/30 (43%)
Dental malocclusion 11/30 (37%)
Low-set ears 6/31 (19%)
Thick helix 8/31 (26%)
NECK
Short or webbed neck 27/31 (87%)
Low posterior hair line 14/30 (47%)
THORAX
Pectus cariantum and/or excavatum 16/31 (52%)
Cardiac anomalies 20/31 (65%)
ABDOMEN
Hepatomegaly and/or splenomegaly 4/30 (13%)




Fetal pads in fingers and toes 21/30 (70%)
Wide and short nails 16/30 (53%)
Cubitus valgus 6/30 (20%)
COLUMN
Vertebral anomalies 8/30 (27%)
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Karyotype was normal in every
proband.
DISCUSSION
NS is considered a frequent auto-
somal dominant disorder and its wide
phenotypic spectrum led these patients
to the attention of different clinicians,
such as, endocrinologists, ophthal-
mologists, cardiologists, pediatricians,
and hematologists. A better understan-
ding of this heterogeneous syndrome
allows a more accurate management of
these patients.
Prenatal history is usually unremar-
kable, but sometimes polyhydramnios
can be detected by fetal ultrasound.
Sharland et al. (1992) 7 observed this
anomaly in 43 of 130 pregnancies of
fetuses affected by NS. It was also
observed in our study, but in just 10%
of pregnancies, probably due to the
lack of ultrasound performed in the
mothers of our patients.
Short stature is proportional and
post-natal. These patients have a
normal birth weight and length. Their
growth decreases by three months of
age and remains consistently below the
5th percentile. 8 The bone age has
usually a two-year delay. In our study,
71% of our patients were three SD
below the mean for height, and 55% of
them showed a delayed bone age.
The most frequent craniofacial
features observed in this study include
hypertelorism, ptosis, downslanting of
the palpebral fissures, high arched
palate and dental malocclusion. Lee et
al. 9 (1992) found ocular anomalies in
95% of 58 patients with NS. The most
common were hypertelorism, refractive
errors, and anterior segment changes,
especially prominent corneal nerves.
This latter was diagnosed in three of
our patients.
Cardiac abnormalities are common
findings in NS, and they are the
principal concern in this disorder. In
our study, 65% of the patients had a
congenital heart defect. This frequency
is higher than the 50% estimated in this
syndrome 10, and it is probably due to
the preferential referral of our patients
from a cardiac clinic.
The most frequent heart defect
observed in our study was pulmonary
stenosis (PS), present in 17 patients out
of 20 with cardiac anomalies (85%).
The prevalence of this heart defect in
NS is well described in the literature
7,11. It was an isolated finding in nine
instances (53%) and when associated
with another cardiac anomaly, the most
common were atrial septal defect
(ASD) and hypertrophic cardiomyo-
pathy (HCM) (three cases each).
The second most common cardiac
anomaly in NS is the HCM 7, also
observed in our study. Unlike the non-
syndromic HCM, in NS it is frequently
associated with a heart defect, espe-
cially PS 12. Here, four out of our five
patients with HCM had associated
pulmonary, aortic, or tricuspid valves
involved.
Other congenital heart defects
observed in our study were a ventri-
cular septal defect (VSD) and valvar
aortic thickened in one patient each.
Noonan 13 (1994) stated that virtually
every type of heart defect has been
described in this disorder.
The EKG showed a superior devia-
tion of the QRS axis in 16 patients
(80%), observed in cases with valvar
pulmonary stenosis (VPS), supravalvar
pulmonary stenosis (SVPS), HCM and
VSD. Superior deviation of the QRS
axis was not found in patients without
cardiac anomalies. This finding is a
helpful tool in the diagnosis of a NS
patient 14.
The cardiac involvement in these
patients is a frequent finding and has
peculiarities when compared to non-
syndromic heart anomalies. Also, these
patients frequently have a chest defor-
mity with pectus carinatum superiorly
and excavatum inferiorly 15, which
interferes with cardiac auscultation.
Therefore, a complete cardiac work-up
should be performed in every patient
with a suspected diagnosis of NS, with
EKG and echocardiogram.
Genital anomalies are frequent in
the males, especially the cryptor-
chidism, considered responsible for the
infertility observed in this group of
patients. Cryptorchidism was observed
in seven (39%) of our male patients
and was bilateral in six of them.
Vertebral anomalies were disco-
vered in 27% of our patients. They
were not prominent clinically and were
mainly spina bifida occulta, scoliosis,
and kyphosis.
Hematological anomalies in NS
involve platelets (number and function)
and coagulation factors, especially
factor XI deficiency 16. In our study,
factor XI deficiency was also the most
common, isolated or associated with
other deficient factors, such as, factor
XII, VIII, IX, and ristocetin cofactor.
There was a poor correlation between
the bleeding history and the coagu-
lation assays findings 16. In our study,
nine patients had anomalies in the
Table 3 - Hematologial findings in 31 patients with NS.
     HEMATOLOGIAL FINDINGS Nº (%)
•  Thrombocytopenia 2/10 (20%)
•  Deficient platelet aggregation 1/10 (10%)
•  Increased BT 1/10 (10%)
•  Isolated FXI deficiency 1/10 (10%)
•  Combined FXI deficiency 2/10 (20%)
•  Isolated FXII deficiency 1/10 (10%)
•  Combined FXII deficiency 1/10 (10%)
•  Isolated FVIII deficiency 1/10 (10%)
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coagulation assays, but only two of
them had a history of bleeding.
NS is both clinically and gene-
tically complex. It is considered an
autosomal dominant disorder with
variable expression and incomplete
penetrance. Molecular studies have
confirmed that it is a heterogeneous
disorder.
In our study, the majority of the
cases were sporadic. Familial instances
were observed in only three families.
The characterization of familial and
sporadic cases is essential for adequate
genetic counseling, requiring a careful
physical examination of all first-degree
relatives 17. The recurrence risk for the
children of an affected person is 50%
and is less than 1% for normal parents
of a child affected by this disorder.
The identification of a marker, by
molecular techniques, would help in
he diagnosis and genetic counseling of
a NS patient. At present, diagnosis
relies primarily on clinical obser-
vations.
RESUMO RHCFAP/2981
BERTOLA, D.R. e col. - Síndrome de
Noonan: um estudo clínico e gené-
tico de 31 pacientes. Rev. Hosp.
Clín. Fac. Med. S. Paulo 54 (5):
147-150,1999.
A síndrome de Noonan é uma
patologia de múltiplas anomalias
congênitas, herdada em um padrão de
herança autossômico dominante. Estu-
damos 31 pacientes (18 do sexo mas-
culino e 13 do sexo feminino) afetados
por essa síndrome quanto aos aspectos
clínicos e genéticos. As características
clínicas mais freqüentemente obser-
vadas foram a baixa estatura (71%); os
dismorfismos craniofaciais, princi-
palmente o hipertelorismo, a ptose e a
inclinação ínfero-lateral das fendas
palpebrais; o pescoço curto ou alado
(87%); as anomalias cardíacas (65%)
e a presença de coxins nas pontas dos
dedos das mãos e pés (70%). Após
e tudarmos os parentes de primeiro
grau dos probandos, fizemos o diag-
nóstico da Síndrome de Noonan em
um deles em três famílias. Portanto, a
maioria dos nossos casos foram espo-
rádicos.
DESCRITORES: Síndrome de
Noonan. Estenose pulmonar valvar.
Autossômica dominante. Probando.
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